Donald L. Trump, M.D., to Speak at 2nd Annual Kentmere Genetic Testing and Utilization Management Conference in Philadelphia

WILMINGTON, Del., June 13, 2016 /PRNewswire/ -- Donald L. (Skip) Trump, M.D., CEO Executive Director of Inova Schar Cancer Institute, has been announced to speak at Kentmere Healthcare Consulting Corporation's 2^nd Annual Genetic Testing and Utilization Management Conference, June 23-24, 2016 in Philadelphia.

Photo - http://photos.prnewswire.com/prnh/20160610/377933LOGO

Dr. Trump has more than two decades of leadership experience with prestigious cancer care, cancer research and cancer education programs.

Prior to joining Inova, Dr. Trump was president and CEO of Roswell Park Cancer Institute in Buffalo, NY, where he also served the institute's associate institute director and SVP for clinical investigations. Dr. Trump was also deputy director for clinical investigations at the University of Pittsburgh Cancer Institute. Before that he was director of experimental therapeutics at Duke Comprehensive Cancer Center.

Dr. Trump's professional associations and appointments include the American Association for Cancer Research, American Society of Clinical Oncology, American Association for the Advancement of Science, Society of Urologic Oncology, American Urological Association, Society for Basic Urologic Research, and the Science Policy & Legislative Affairs Committee.

At the conference, Dr. Trump will speak on the topic, "How Research Drives the Evolution of Prostate Cancer Screening and Molecular Profiling." Epidemiologic and outcome data coupled with genome profiling in prostate cancer have resulted in the rapid evolution of PSA screening and prostate cancer treatment guidelines. The basis for these guidelines will be presented.

Additional conference topics include:

• The Power of NGS: Non-Invasive Prenatal Testing and Liquid Biopsies
• Pharmacogenomics and the Basis of Targeted, Personalized Therapies: The Right Drug at the Right Time to the Right Person
• Navigating the Minefield of Genetic Testing UM; Operational, Financial and Medical

Additional conference speakers include:

• Russel Kaufman, MD, FACP, FCCP, Chief Medical Officer, Kentmere Healthcare Consulting Corporation; Hematologist/Oncologist and Cancer Geneticist; former Dean and Vice-Chancellor, Duke University Medical School; former CEO, The Wistar Institute
• Mike Barlow, Vice President, Palmetto GBA, Centers for Medicare & Medicaid Services Medicare Administrative Contractors
• Elaine Jeter, MD, MolDx Medical Director, Palmetto GBA, Centers for Medicare & Medicaid Services Medicare Administrative Contractors
• Edith Mitchell, MD, FACP, Program Leader, Gastrointestinal Oncology at Sidney Kimmel Medical College at Thomas Jefferson University; President, National Medical Association

The Kentmere Genetic Testing and Utilization Management Conference is designed for Health Plans and will present the latest ideas on where they should focus their efforts for genetic testing in the future, as well as the latest news on CMS genetic testing reimbursement and American Association for Cancer Research cancer genetic testing. It is exclusively for Health Plan and ACO Medical Directors, Network Management Executives, Medical Policy and Reimbursement/Contracting personnel, as well as anyone involved in utilization management of genetic and laboratory tests.

Registration* and further information can be found at http://kentmere-healthcare-consulting.ticketleap.com/2016genetic

*Kentmere has the right to deny admission and refund ticket purchases made by or for any organization and/or person that is not a Health Plan or ACO or an employee of a Health Plan or ACO.

About Kentmere Healthcare Consulting Corporation

Since 2000, Kentmere Healthcare Consulting Corporation provides its proprietary outpatient Kentmere Laboratory Benefit Management Program™ for the managed care industry, which manages Health Plan utilization, cost, and mix of outpatient clinical, pathology, and genomic laboratory testing. Kentmere exclusively serves national and regional health plans, is not a laboratory, and does not work for or with laboratory providers.

Contact:

Danielle Ellis, Kentmere Healthcare Consulting Corporation

302-478-7600 / Email

SOURCE Kentmere Healthcare Consulting Corporation